Synlogic
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Synlogic and other ETFs, options, and stocks.About SYBX
Synlogic, Inc. is a biopharmaceutical company which engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs.
CEOMary Beth Dooley
CEOMary Beth Dooley
Employees1
Employees1
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2007
Founded2007
Employees1
Employees1
SYBX Key Statistics
Market cap13.69M
Market cap13.69M
Price-Earnings ratio-4.41
Price-Earnings ratio-4.41
Dividend yield—
Dividend yield—
Average volume33.01K
Average volume33.01K
High today$1.19
High today$1.19
Low today$1.12
Low today$1.12
Open price$1.12
Open price$1.12
Volume21.53K
Volume21.53K
52 Week high$1.96
52 Week high$1.96
52 Week low$0.898
52 Week low$0.898
Stock Snapshot
As of today, Synlogic(SYBX) shares are valued at $1.17. The company's market cap stands at 13.69M, with a P/E ratio of -4.41.
On 2026-01-04, Synlogic(SYBX) stock traded between a low of $1.12 and a high of $1.19. Shares are currently priced at $1.17, which is +4.5% above the low and -1.7% below the high.
Synlogic(SYBX) shares are trading with a volume of 21.53K, against a daily average of 33.01K.
During the past year, Synlogic(SYBX) stock moved between $0.90 at its lowest and $1.96 at its peak.
During the past year, Synlogic(SYBX) stock moved between $0.90 at its lowest and $1.96 at its peak.
People also own
Based on the portfolios of people who own SYBX. This list is generated using Robinhood data, and it’s not a recommendation.